SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML Trademark
Trademark Overview
On Wednesday, November 13, 2024, a trademark application was filed for SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML with the United States Patent and Trademark Office. The USPTO has given the SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML trademark a serial number of 98851706. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 26, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Injectors for medical purposes, namely, medical fluid injectors
Pharmaceutical preparations for the treatment of autoimmune diseases
General Information
| Serial Number | 98851706 |
| Word Mark | SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML |
| Filing Date | Wednesday, November 13, 2024 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, November 26, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Injectors for medical purposes, namely, medical fluid injectors |
| Indication of Colors claimed | The color(s) teal, burgundy and black is/are claimed as a feature of the mark. |
| Pseudo Mark | SIMLANDI ADALIMUMABRYVK INJECTION FORTY MILLIGRAMS POINT FOUR MILLILITERS |
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune diseases |
| Description of Mark | The mark consists of Leaf design in teal and burgundy and word SIMLANDI in teal and adalimumab-ryvk in black. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, March 1, 2024 |
| First Use In Commerce Date | Friday, March 1, 2024 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Friday, March 1, 2024 |
| First Use In Commerce Date | Friday, March 1, 2024 |
Trademark Owner History
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
Trademark Events
| Event Date | Event Description |
| Wednesday, November 13, 2024 | NEW APPLICATION ENTERED |
| Wednesday, May 7, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 7, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 8, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, May 14, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 14, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 14, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, August 14, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, November 26, 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, November 26, 2025 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
